Sol_75N98026Q01130.pdf

REQUEST FOR QUOTATION

(THIS IS NOT AN ORDER)

THIS RFQ IS IS NOT A SMALL BUSINESS SET-ASIDE

15. DATE OF QUOTATION

16. SIGNER

a. NAME (Type or print)

c. TITLE (Type or print)

b. TELEPHONE

AREA CODE

NUMBER

STANDARD FORM 18 (REV. 6/1995)

Prescribed by GSA-FAR (48 CFR) 53.215-1(a)

AUTHORIZED FOR LOCAL REPRODUCTION

Previous edition not usable

8. TO:

b. COMPANYa. NAME

c. STREET ADDRESS

d. CITY e. STATE f. ZIP CODE

9. DESTINATION

a. NAME OF CONSIGNEE

b. STREET ADDRESS

d. STATE e. ZIP CODE

7. DELIVERY

FOB DESTINATION

OTHER

(See Schedule)

10. PLEASE FURNISH QUOTATIONS TO THE

ISSUING OFFICE IN BLOCK 5a ON OR BEFORE CLOSE OF BUSINESS (Date)

IMPORTANT: This is a request for information and quotations furnished are not offers. If you are unable to quote, please so indicate on this form and return it to the address in Block 5a. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service. Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this Request for Quotation must be completed by the quoter.

11. SCHEDULE (Include applicable Federal, State and local taxes)

ITEM NUMBER

(a)

SUPPLIES/SERVICES

(b)

QUANTITY

(c)

UNIT

(d)

UNIT PRICE

(e)

AMOUNT

(f)

12. DISCOUNT FOR PROMPT PAYMENT

a. 10 CALENDAR DAYS (%) b. 20 CALENDAR DAYS (%) c. 30 CALENDAR DAYS (%) d. CALENDAR DAYS

NUMBER PERCENTAGE

NOTE: Additional provisions and representations are are not attached.

13. NAME AND ADDRESS OF QUOTER

a. NAME OF QUOTER

b. STREET ADDRESS

c. COUNTY

d. CITY e. STATE f. ZIP CODE

14. SIGNATURE OF PERSON AUTHORIZED TO

SIGN QUOTATION

PAGE OF PAGES

1. REQUEST NUMBER 2. DATE ISSUED 3. REQUISITION/PURCHASE REQUEST NUMBER 4. CERT. FOR NAT. DEF.

UNDER BDSA REG. 2

AND/OR DMS REG. 1

RATING

5a. ISSUED BY 6. DELIVER BY (Date)

NAME TELEPHONE NUMBER

AREA CODE NUMBER

c. CITY

5b. FOR INFORMATION CALL (NO COLLECT CALLS)

National Institutes of Health OD - Office of Logistics and Acquisition Operations 6100 Executive Blvd., Room 6B05 Bethesda, MD 20892-7511

75N98026Q01130

CASSIE RUNNER

+13

014-808827

09/02/2026

09/12/2026 1400 ED

Multiple

The purpose of this NON-COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION is to acquire Service Agreement for MicoBeta2

Instrument.

The following FAR clauses and Provisions are applicable to this award.

FAR 52.204-13 System for Award

Management Maintenance (Oct 2018)

FAR 52.204-18 Commercial and Government

Entity Code Maintenance (Aug 2020)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity

Investigations (Dec 2015)

FAR 52.212-4 Contract Terms and

Continued...

1 7

CONTINUATION SHEET

REFERENCE NO. OF DOCUMENT BEING CONTINUED PAGES

NAME OF OFFEROR OR CONTRACTOR

SUPPLIES/SERVICES

(B)

UNIT

(D)

UNIT PRICE

(E)

AMOUNT

(F)

OPTIONAL FORM 336 (4-86)

Sponsored by GSA FAR (48 CFR) 53.110

ITEM NO.

(A)

QUANTITY

(C)

NSN 7540-01-152-8067

75N98026Q01130

Conditions -In addition to all the applicable commercial Products and Commercial Services

(Nov 2023)

FAR 52.217-8 Option to Extend Services (Nov

1999)

FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE

NON-COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION

Title: Procurement of Service Agreement for MicoBeta2 Instrument

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q01130. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a Firm-Fixed Price award on a non-competitive basis to Revvity Health Sciences, Inc. 68 Elm Street Hopkinton MA 01748 to acquire Service Agreement for MicoBeta2 Instrument.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular, FAC 2026-01, March 2026.

(iv) NAICS Code: 811210: Electronic and Precision Equipment Repair and Maintenance the small business size standard is “$34 million”.

Set aside Status: This requirement is NOT set aside for small business.

(v) Description of Requirement:

To maintain the instrument in optimal operating condition and minimize downtime that could adversely affect laboratory operations and research activities. The required service contract will provide comprehensive coverage, including:

• Unlimited repair visits, including travel and labor;

• Replacement parts required for corrective maintenance;

• Priority response for instrument failures;

• Remote technical support;

• Preventive maintenance;

• Minor hardware and software updates;

• A 15% discount on applicable training services

Delivery Location:

NIH: Triad Technology Center

333 CASSELL DR

RM 3501

BALTIMORE MD 21224

(vii) [Reserved, if needed]

(viii) The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any additional instructions as required.

(ix) The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

(a) A written notice of award or acceptance of an offer, issued to the successful offeror within the time specified in the offer, shall result in a binding contract without further action by either party.

The Government reserves the right to accept any offer (or part of an offer) before the expiration date, whether or not discussions are conducted, unless a written notice of withdrawal is received prior to award. Add additional evaluation criteria as required.

(x) Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer.

(xi) FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

(xii) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items, applies to this acquisition.

(xiii) Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices: None.

(xiv) The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.

(xv) Submission Requirements:

Responses must include sufficient information to demonstrate the respondent’s capability to provide the required product or service. Price quotations shall include, at a minimum: unit price, list price, shipping and handling costs, delivery timeframe after award, delivery terms, prompt payment discount terms, F.O.B. point (destination or origin), product or catalog numbers, product descriptions, and any other relevant information.

Evaluation factors may include, but are not limited to: past performance, technical capability, special features, trade-in considerations, expected lifecycle, warranty, maintenance availability, and environmental or energy efficiency considerations.

Respondents claiming to be manufacturers or authorized resellers of a specified brand-name product must provide:

(a) Product, catalog, model, and/or part number(s);

(b) Product description;

(c) Documentation demonstrating that the offered item meets all required salient characteristics;

(d) Quantity;

(e) Estimated price or cost;

(f) Shipping, handling, and/or installation charges; and

(g) Delivery timeframe after receipt of order.

Responses must also include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

All responses must be received by September 12, 2026, and 2PM (1400) EST and must reference solicitation number 75N98026Q01130. Responses may be submitted electronically to cassie.runner@nih.gov.

(xvi) Point of Contact:

Cassie Runner, Contract Specialist, cassie.runner@nih.gov, 301-480-8827 mailto:cassie.runner@nih.gov

Service Plan for MicroBeta 2 Instrument Statement of Work

June 8, 2026 Introduction:

The mission of the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) is to conduct a program of basic and applied research in the areas of drug abuse and dependence. As part of this effort, the NIDA IRP conducts multidisciplinary research into the mechanism of addiction and brain functions. The Drug Designer Research Unit (DDRU) studies the effects of newly emerging drugs of abuse using molecular, cellular, and whole-animal methods.

Purpose and Objectives:

The NIDA DDRU has a need for a service plan on our Revvity MicroBeta2 instrument.

The service agreement is to prevent too much down time in the event of equipment breakdown and to keep the instrument in proper working order at all times due to the necessity of the instrument for data analysis for in-vitro experiments.

Project Requirements:

The Revvity MicroBeta2 instrument requires a service plan that includes two preventive maintenance visits, parts, travel, labor, and phone support. The PM visit should include mechanical, hydraulic, and electrical check of the system, a comprehensive check-up of the system specifications and operational functions, replacement of worn parts, and software and firmware updates. The preventative maintenance visits need to be performed by a trained engineer and all parts should be genuine Revvity parts.

Period of Performance:

The period of performance shall be one calendar year from date of award.

Contract Type:

Use of a firm fixed price purchase order is anticipated.

Independent Government Cost Estimate:

The total estimated cost to perform the tasks indicated in this statement of work for a twelve-month period of performance is $22288.00.

Acquisition History:

Previous acquisition for this work is PO# 75N95025P00331.

Sole Source Requirement:

Revvity Health Sciences Inc.

68 Elm St.

Hopkinton, MA 01748

(800) 762-4000

The Revvity Microbeta2 instrument must be maintained by Revvity Health Sciences Inc.

and replacement parts and accessories must be compatible with the existing equipment and thus cannot be from any other sources. The Revvity MicroBeta2 instrument is very important piece of equipment to two NIDA sections for analyzing radioactive experimental data. We must continue the maintenance on this instrument to avoid long delays in analyzing data which will ruin experiments and waste a significant amount of federal government money.

Title